FeesSafety
Pluang+

MDPI journals now indexed in Scite, accessible via AI tools like ChatGPT with verified citations.

Market News
06 Oct 2026, 15:00 WIB
PRNewsWire
View Source
Bullish
MDPI journals now indexed in Scite, accessible via AI tools like ChatGPT with verified citations.

MDPI, an open access publisher, has partnered with Research Solutions to index its journals in Scite, making them discoverable through AI tools such as ChatGPT, Claude, and Microsoft Copilot. This integration provides researchers with verified citations, direct links to original articles, and usage analytics, improving research discovery and attribution in AI environments. The move addresses challenges of unverified references in AI-generated content and enhances visibility for MDPI publications. This collaboration marks a significant step in making scientific research more accessible and accurately represented in AI-driven platforms.

Research Solutions' collaboration with MDPI to enhance discoverability and attribution of open access research is the story's subject, with Pluang's market data providing context. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 06, 2026 17:51 WIB: Out of 150 priced US technology stocks, 120 rose and 28 fell today. Notable movers include OKTA at USD 221.92 with a 1-day change of +1.66% and Pluang order activity of 89% Sell / 11% Buy, SHOP at USD 162.76 with a +1.66% change and 99% Sell / 1% Buy activity, and HPE at USD 69.50 with a +1.64% change and 25% Sell / 75% Buy activity. Typical hold times range from 34 to 77 days.

More News

Novartis forecasts 5% sales growth CAGR through 2031 with upgraded peak sales for key drugs.

Novartis forecasts 5% sales growth CAGR through 2031 with upgraded peak sales for key drugs.

Novartis projects a 5% compound annual growth rate (CAGR) in net sales from 2026 to 2031 and aims to restore its core operating income margin to over 40% by 2029. The company raised peak sales forecasts for key drugs Kesimpta, Scemblix, and Leqvio, r...

Company Fundamentals
Bullish
18 minutes ago
EU approves Sanofi's new-generation rabies vaccine VaxRabeo for all ages

EU approves Sanofi's new-generation rabies vaccine VaxRabeo for all ages

Sanofi's new rabies vaccine, VaxRabeo, has been approved by the European Commission for use in all age groups for both pre-exposure and post-exposure prophylaxis. The vaccine, made with advanced Vero cell technology, offers longer shelf life and bett...

Market News
Bullish
18 minutes ago
GQG Partners lists its first actively managed US equity ETF on Abu Dhabi Securities Exchange

GQG Partners lists its first actively managed US equity ETF on Abu Dhabi Securities Exchange

GQG Partners has listed its first actively managed US equity ETF, GQG US Equity ETF (GQGU), on the Abu Dhabi Securities Exchange (ADX). This marks GQG's first ETF listing outside the US, expanding regional investor access to its US stock investment s...

Company Fundamentals
Bullish
18 minutes ago
gategroup provides specialized inflight catering for Pope Leo XIV's historic South America trip

gategroup provides specialized inflight catering for Pope Leo XIV's historic South America trip

gategroup, a global leader in airline catering, supplied specialized onboard catering and logistical support for Pope Leo XIV's apostolic journey across South America. Collaborating with ITA Airways, Aerolíneas Argentinas, and LATAM Airlines, gategro...

Bullish
18 minutes ago
GRAIL nears FDA approval for Galleri cancer test, boosting market potential and scaling costs.

GRAIL nears FDA approval for Galleri cancer test, boosting market potential and scaling costs.

GRAIL reported strong growth in its Galleri multi-cancer early detection test, completing over 174,000 tests in nine months of 2026 and seeing a 24% volume increase in Q3. A positive FDA advisory vote positions Galleri to become the first FDA-approve...

Company Fundamentals
Bullish
25 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App